gfh018
Small moleculeexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Aug 10, 2021 (NCT04914286)
Timeline
Indications
Mechanism of action
- TGF-beta receptor type-1INHIBITOR
TGFBR1 inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05386888 | Phase 2 | Sep 1, 2022 | Zhejiang Genfleet Therapeutics Co., Ltd. |
| NCT05051241 | Phase 1 | Sep 30, 2021 | Zhejiang Genfleet Therapeutics Co., Ltd. |
| NCT04914286 | Phase 1/Phase 2 (Phase 2) | Aug 10, 2021 | Zhejiang Genfleet Therapeutics Co., Ltd. |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Zhejiang Genfleet Therapeutics Co., Ltd. | For profit | 3 | 3 | 2 | 2021 |
1 organizations
Page 1 / 1